Homepage
Medication Guide
Precautions for Administration of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation, whose main ingredients are Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE).Precaut...
509
Friday, September 19th, 2025, 15:45
How to Use ExtraSuperTadarise
ExtraSuperTadarise is a combination preparation containing two active ingredients, Tadalafil and Dapoxetine. It is used for the treatment of male erectile dysfunction (ED) and premature ejaculation (P...
525
Friday, September 19th, 2025, 15:42
Indications of ExtraSuperTadarise
ExtraSuperTadarise is a combined preparation mainly used for the treatment of male erectile dysfunction (ED) and premature ejaculation (PE). As an enhanced formulation of Tadalafil, it combines the me...
506
Friday, September 19th, 2025, 15:35
What Are the Side Effects of Etrasimod?
Etrasimod is a sphingosine-1-phosphate (S1P) receptor modulator indicated for the treatment of moderately to severely active ulcerative colitis (UC) in adults. It exerts its therapeutic effect by reve...
510
Friday, September 19th, 2025, 15:31
What Is the Therapeutic Efficacy of Etrasimod?
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator. It was approved for marketing by the U.S. FDA in 2023 for the treatment of moderate to severe active ulcerative colitis (UC) in adults....
507
Friday, September 19th, 2025, 15:26
Etrasimod: Precautions and Monitoring for Medication Use
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severe active ulcerative colitis (UC) in adults.Etrasimod: Precautions and Monitoring for Med...
508
Friday, September 19th, 2025, 15:20
Conventional Dosage and Administration
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator indicated for the treatment of moderate to severe active ulcerative colitis (UC) in adults.How to Use EtrasimodConventional Dosage and A...
508
Friday, September 19th, 2025, 14:51
Indication of Etrasimod
Etrasimod is a sphingosine 1-phosphate (S1P) receptor modulator developed by ViiV Healthcare, which was first approved in the United States in 2023. As a novel oral medication for the treatment of ulc...
507
Friday, September 19th, 2025, 14:44
Indication of Qlosi Eye Drops
Qlosi Eye Drops is a cholinergic agonist ophthalmic solution developed by Orasis Pharmaceuticals, intended for the treatment of presbyopia. As an innovative ophthalmic medication, Qlosi improves near ...
506
Friday, September 19th, 2025, 14:38
What Are the Side Effects of Cabotegravir?
Cabotegravir is an HIV-1 integrase strand transfer inhibitor (INSTI) that must be used in combination with Rilpivirine (EDURANT). It is indicated for the short-term treatment of virologically suppress...
502
Friday, September 19th, 2025, 14:25
111 / 207
2069 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved